RU95121639A - Аза циклогексапептидные соединения - Google Patents
Аза циклогексапептидные соединенияInfo
- Publication number
- RU95121639A RU95121639A RU95121639/04A RU95121639A RU95121639A RU 95121639 A RU95121639 A RU 95121639A RU 95121639/04 A RU95121639/04 A RU 95121639/04A RU 95121639 A RU95121639 A RU 95121639A RU 95121639 A RU95121639 A RU 95121639A
- Authority
- RU
- Russia
- Prior art keywords
- compound according
- iii
- dimethyltridecyl
- conh
- alkyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims 15
- -1 9,11-dimethyltridecyl Chemical group 0.000 claims 8
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 6
- 125000000217 alkyl group Chemical group 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 4
- 125000003342 alkenyl group Chemical group 0.000 claims 3
- 230000000845 anti-microbial Effects 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 206010017533 Fungal infection Diseases 0.000 claims 1
- 206010035664 Pneumonia Diseases 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 125000005036 alkoxyphenyl group Chemical group 0.000 claims 1
- 230000000843 anti-fungal Effects 0.000 claims 1
- 239000004599 antimicrobial Substances 0.000 claims 1
- 230000036039 immunity Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
- 230000001225 therapeutic Effects 0.000 claims 1
Claims (14)
1. Соединение формулы
где R1 - H или OH;
R2 - H, CH3 или OH;
R3 - H, CH3, CH2CN, CH2CH2NH2 или CH2CONH2;
RI - C9 - C21алкил, C9 - C21алкенил, C1-C10алкоксифенил или C1-C10алкоксинафтил;
RII - H, C1 - C4алкил, C3-C4алкенил, (CH2)2-4OH, (CH2)2-4NRIVRV, CO(CH2)1-4NH2;
RIII - H, C1 - C4алкил, C3 - C4алкенил, (CH2)2-4OH, (CH2)2-4NRIVRV
или
RII и RIII взятые вместе - (CH2)4-, -(CH2)5-, -(CH2)2O(CH2)2-, -(CH2)2NH(CH2)2-;
RIV - H или C1 - C4алкил;
RV - H или C1 - C4алкил;
и их аддитивные соли кислоты.
где R1 - H или OH;
R2 - H, CH3 или OH;
R3 - H, CH3, CH2CN, CH2CH2NH2 или CH2CONH2;
RI - C9 - C21алкил, C9 - C21алкенил, C1-C10алкоксифенил или C1-C10алкоксинафтил;
RII - H, C1 - C4алкил, C3-C4алкенил, (CH2)2-4OH, (CH2)2-4NRIVRV, CO(CH2)1-4NH2;
RIII - H, C1 - C4алкил, C3 - C4алкенил, (CH2)2-4OH, (CH2)2-4NRIVRV
или
RII и RIII взятые вместе - (CH2)4-, -(CH2)5-, -(CH2)2O(CH2)2-, -(CH2)2NH(CH2)2-;
RIV - H или C1 - C4алкил;
RV - H или C1 - C4алкил;
и их аддитивные соли кислоты.
2. Соединение по п.1, где R1 - OH, R2 - H, R3 - CH2CONH2, RI - 9,11-диметилтридецил, RII - H и RIII - CH2CH2NH2.
3. Соединение по п.1, где R1 - OH, R2 - H, R3 - CH2CH2NH2, RI - 9,11-диметилтридецил, RII - H и RIII - CH2CH2NH2.
4. Соединение по п.1, где R1 - OH, R2 - H, R3 - CH2CONH2, RI - 9,11-диметилтридецил, RII и RIII - H.
5. Соединение по п.1, где R1 - H, R2 - H, R3 - CH2CONH2, RI - 9,11-диметилтридецил, RII и RIII - H.
6. Соединение по п.1, где R1 - H, R2 - H, R3 - CH2CONH2, RI - 9,11-диметилтридецил, RII и RIII - COCH2CH2NH2.
7. Соединение по п.1, где R1 - H, R2 - H, R3 - CH2CONH2, RI - 9,11-диметилтридецил, RII - Н и RIII - CH2CH2NH2.
8. Соединение по п.1, где R1 - H, R2 - H, R3 - CH2CH2NH2, RI - 9,11-диметилтридецил, RII и RIII - H.
9. Соединение по п.1, где R1 - H, R2 - H, R3 - CH2CH2NH2, RI - 9,11-диметилтридецил, RII - H и RIII - CH2CH2NH2.
10. Антимикробная композиция, включающая в себя соединение по п.1 в смеси с фармацевтически приемлемым носителем.
11. Антимикробная композиция, включающая в себя соединение по п.2 в смеси с фармацевтически приемлемым носителем.
12. Способ лечения грибковых инфекций, включающий в себя введение противогрибковой дозы соединения по п.1 особям рода млекопитающих в лечебных целях.
13. Способ лечения пневмоцистической пневмонии у пациентов с пониженным иммунитетом, включающий в себя введение терапевтически эффективной дозы соединения по п.1.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US032847 | 1993-03-16 | ||
US08/032,847 US5378804A (en) | 1993-03-16 | 1993-03-16 | Aza cyclohexapeptide compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
RU95121639A true RU95121639A (ru) | 1997-09-20 |
RU2122548C1 RU2122548C1 (ru) | 1998-11-27 |
Family
ID=21867140
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU95121639A RU2122548C1 (ru) | 1993-03-16 | 1994-03-10 | Циклические пептиды или их аддитивные соли кислоты, композиция, проявляющая противогрибковую и антипневмоцистную активность, способ лечения грибковых инфекций |
Country Status (33)
Country | Link |
---|---|
US (3) | US5378804A (ru) |
EP (1) | EP0620232B1 (ru) |
JP (1) | JP2568474B2 (ru) |
KR (1) | KR100329693B1 (ru) |
CN (1) | CN1098274C (ru) |
AT (1) | ATE186736T1 (ru) |
AU (1) | AU668804B2 (ru) |
BG (1) | BG63047B1 (ru) |
BR (2) | BR9406009A (ru) |
CA (1) | CA2118757C (ru) |
CZ (1) | CZ286235B6 (ru) |
DE (2) | DE69421639T2 (ru) |
DK (1) | DK0620232T3 (ru) |
ES (1) | ES2139043T3 (ru) |
FI (1) | FI109542B (ru) |
GR (1) | GR3031872T3 (ru) |
HK (1) | HK1008674A1 (ru) |
HR (1) | HRP940161B1 (ru) |
HU (2) | HU217614B (ru) |
IL (1) | IL108892A (ru) |
LU (1) | LU90875I2 (ru) |
LV (1) | LV12574B (ru) |
NL (1) | NL300076I2 (ru) |
NO (2) | NO318372B1 (ru) |
NZ (1) | NZ263360A (ru) |
PL (1) | PL179261B1 (ru) |
RO (1) | RO113246B1 (ru) |
RU (1) | RU2122548C1 (ru) |
SI (1) | SI9420013B (ru) |
SK (1) | SK282527B6 (ru) |
UA (1) | UA59329C2 (ru) |
WO (1) | WO1994021677A1 (ru) |
ZA (1) | ZA941807B (ru) |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5874403A (en) * | 1992-10-15 | 1999-02-23 | Merck & Co., Inc. | Amino acid conjugates of cyclohexapeptidyl amines |
US5378804A (en) * | 1993-03-16 | 1995-01-03 | Merck & Co., Inc. | Aza cyclohexapeptide compounds |
US5948753A (en) * | 1993-05-04 | 1999-09-07 | Merck & Co., Inc. | Cyclohexapeptidyl propanolamine compounds |
DE69513408T2 (de) * | 1994-08-23 | 2000-06-08 | Merck & Co Inc | Ein verbessertes verfahren für die herstellung von seitenketten-derivaten von cyclohexapeptidyl-lipopeptiden |
ATE223226T1 (de) * | 1994-09-16 | 2002-09-15 | Merck & Co Inc | Azazyklohexapeptid-verbindungen |
US5516757A (en) * | 1994-09-16 | 1996-05-14 | Merck & Co., Inc. | Semi-synthetic lipopeptides, compositions containing said lipopeptides, and methods of use |
US5514651A (en) * | 1994-09-16 | 1996-05-07 | Merck & Co., Inc. | Aza cyclohexapeptide compounds |
US5516756A (en) * | 1994-10-31 | 1996-05-14 | Merck & Co., Inc. | Aza cyclohexapeptide compounds |
CA2211138A1 (en) * | 1995-01-26 | 1996-08-01 | Merck & Co., Inc. | Novel antifungal cyclohexapeptides |
US5552521A (en) * | 1995-02-10 | 1996-09-03 | Merck & Co., Inc. | Process for preparing certain aza cyclohexapeptides |
EP0862579A1 (en) * | 1995-11-09 | 1998-09-09 | Merck & Co., Inc. | Cyclohexapeptidyl bisamine compound, compositions containing said compound and methods of use |
US5952300A (en) * | 1996-04-19 | 1999-09-14 | Merck & Co., Inc. | Antifungal compositions |
AR006598A1 (es) * | 1996-04-19 | 1999-09-08 | Merck Sharp & Dohme | "composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación" |
HRP970318B1 (en) * | 1996-06-14 | 2002-06-30 | Merck & Co Inc | A process for preparing certain aza cyclohexapeptides |
USRE38984E1 (en) * | 1996-09-12 | 2006-02-14 | Merck & Co., Inc. | Antifungal combination therapy |
ATE248625T1 (de) * | 1996-09-12 | 2003-09-15 | Merck & Co Inc | Fungizide kombinationstherapie |
US5854212A (en) * | 1996-10-23 | 1998-12-29 | Merck & Co., Inc. | Cyclohexapeptidyl bisamine compound, compositions containing said compound and methods of use |
US5936062A (en) * | 1997-06-12 | 1999-08-10 | Merck & Co., Inc. | Process for preparing certain aza cyclohexapeptides |
AU6564000A (en) * | 1999-07-27 | 2001-02-13 | Aventis Pharma Deutschland Gmbh | Novel cyclohexapeptide compounds, processes for their production and their use as a pharmaceutical |
AR035808A1 (es) * | 2001-04-12 | 2004-07-14 | Merck & Co Inc | Proceso de deshidratacion capaz de minimizar la epimerizacion de un grupo hidroxilo por ciertas equinocandinas |
EP2266590A3 (en) | 2002-02-22 | 2011-04-20 | Shire LLC | Active agent delivery sytems and methods for protecting and administering active agents |
US7214768B2 (en) * | 2002-04-08 | 2007-05-08 | Merck & Co., Inc. | Echinocandin process |
EP1654036B1 (en) * | 2003-07-22 | 2007-12-26 | Theravance, Inc. | Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent |
EP1730180A4 (en) * | 2004-02-24 | 2008-06-18 | Commw Scient Ind Res Org | ANTIFUNGAL PEPTIDES |
EP1785432A1 (en) * | 2005-11-15 | 2007-05-16 | Sandoz AG | Process and intermediates for the synthesis of caspofungin. |
SI2049142T2 (sl) * | 2006-07-26 | 2016-04-29 | Sandoz Ag | Formulacije kaspofungina |
TW200826957A (en) * | 2006-10-16 | 2008-07-01 | Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag | Purification processes for echinocandin-type compounds |
CA2692053A1 (en) * | 2007-06-26 | 2008-12-31 | Merck Sharp & Dohme Corp. | Lyophilized anti-fungal composition |
US20090075870A1 (en) * | 2007-09-17 | 2009-03-19 | Protia, Llc | Deuterium-enriched caspofungin |
WO2009142761A1 (en) * | 2008-05-21 | 2009-11-26 | Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag | Caspofungin bo free of caspofungin co |
US8048853B2 (en) * | 2008-06-13 | 2011-11-01 | Xellia Pharmaceuticals Aps | Process for preparing pharmaceutical compound and intermediates thereof |
EP2240507A2 (en) * | 2008-06-25 | 2010-10-20 | TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság | Processes for preparing high purity aza cyclohexapeptides |
EP2183271A1 (en) * | 2008-06-25 | 2010-05-12 | TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság | Caspofungin free of caspofungin impurity a |
WO2010064219A1 (en) | 2008-12-04 | 2010-06-10 | Ranbaxy Laboratories Limited | Process for the preparation of a novel intermediate for caspofungin |
TW201024322A (en) * | 2008-12-31 | 2010-07-01 | Chunghwa Chemical Synthesis & Biotech Co Ltd | Preparation method for nitrogen containing heterocyclic hexapeptide with high conversion rate |
WO2010108637A1 (en) | 2009-03-27 | 2010-09-30 | Axellia Pharmaceuticals Aps | Crystalline compound |
CN101602795B (zh) * | 2009-07-20 | 2011-12-21 | 中国人民解放军第二军医大学 | 环六脂肽胺类抗真菌化合物及其盐类和制备方法 |
EP2463293A4 (en) * | 2009-08-06 | 2013-06-05 | Shanghai Techwell Biopharm Co | AZACYCLOHEXAPEPTIDE BZW. ITS PHARMACEUTICAL ACCEPTABLE SALT, MANUFACTURING PROCESS AND USE |
US8751760B2 (en) * | 2009-10-01 | 2014-06-10 | Dell Products L.P. | Systems and methods for power state transitioning in an information handling system |
CN101792486A (zh) * | 2010-04-12 | 2010-08-04 | 浙江海正药业股份有限公司 | 一种合成醋酸卡泊芬净的方法 |
CN102219832B (zh) | 2010-04-15 | 2013-08-21 | 上海天伟生物制药有限公司 | 一种氮杂环六肽或其盐的纯化方法 |
HUE030464T2 (en) | 2010-09-20 | 2017-05-29 | Xellia Pharmaceuticals Aps | Caspofungin preparation |
JP6000254B2 (ja) * | 2010-09-29 | 2016-09-28 | 上海天偉生物制薬有限公司 | 環状リポペプチド化合物又はその塩の精製方法 |
US8877777B2 (en) * | 2010-09-30 | 2014-11-04 | Shanghai Techwell Biopharmaceutical Co., Ltd. | Process for purifying cyclolipopeptide compounds or the salts thereof |
CN102367267B (zh) | 2010-11-10 | 2013-09-04 | 上海天伟生物制药有限公司 | 一种卡泊芬净的制备方法 |
CN102367268B (zh) | 2010-11-10 | 2013-11-06 | 上海天伟生物制药有限公司 | 一种卡泊芬净类似物及其用途 |
CN102367269B (zh) | 2010-11-10 | 2013-11-06 | 上海天伟生物制药有限公司 | 一种卡泊芬净类似物及其制备方法和用途 |
KR101331984B1 (ko) | 2010-12-09 | 2013-11-25 | 종근당바이오 주식회사 | 카스포펀진 제조방법 및 그의 신규 중간체 |
US20140005355A1 (en) * | 2011-01-03 | 2014-01-02 | Biocon Limited | Process for preparation of caspofungin acetate and intermediates |
CN102618606B (zh) * | 2011-01-30 | 2014-09-10 | 浙江海正药业股份有限公司 | 一种棘白菌素生物转化方法 |
RS56426B1 (sr) | 2011-03-03 | 2018-01-31 | Cidara Therapeutics Inc | Antigljivična sredstva i njihova upotreba |
CN102746384B (zh) | 2011-04-22 | 2016-01-20 | 上海天伟生物制药有限公司 | 一种高纯度的卡泊芬净或其盐及其制备方法和用途 |
TWI597293B (zh) | 2011-04-28 | 2017-09-01 | 江蘇盛迪醫藥有限公司 | 用於合成卡帕芬淨的中間體及其製備方法 |
HUE063336T2 (hu) | 2012-03-19 | 2024-01-28 | Cidara Therapeutics Inc | Adagolási rend echinokandin osztályba tartozó vegyületekhez |
PT2922530T (pt) | 2012-11-20 | 2016-12-22 | Fresenius Kabi Usa Llc | Formulações de acetato de caspofungina |
CN112110991A (zh) * | 2014-12-24 | 2020-12-22 | 上海天伟生物制药有限公司 | 一种含氮杂环六肽前体的组合物及其制备方法和用途 |
WO2017034961A1 (en) | 2015-08-21 | 2017-03-02 | Trilogy Therapeutics, Inc. | Methods of treating lung infection with caspofungin |
US10369188B2 (en) | 2016-01-08 | 2019-08-06 | Cidara Therapeutics, Inc. | Methods for preventing and treating pneumocystis infections |
EP3430400B1 (en) | 2016-03-16 | 2023-06-21 | Cidara Therapeutics, Inc. | Dosing regimens for treatment of fungal infections |
WO2017185030A1 (en) * | 2016-04-22 | 2017-10-26 | Fresenius Kabi Usa, Llc | Caspofungin formulation with low impurities |
EP3651801A4 (en) | 2017-07-12 | 2021-04-07 | Cidara Therapeutics, Inc. | COMPOSITIONS AND METHODS OF TREATMENT OF MUSHROOM INFECTION |
WO2019157453A1 (en) | 2018-02-12 | 2019-08-15 | Trilogy Therapeutics, Inc. | Caspofungin compositions for inhalation |
EP3620462A1 (en) | 2018-09-04 | 2020-03-11 | Xellia Pharmaceuticals ApS | Process for the preparation of caspofungin |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2704030A1 (de) * | 1976-02-12 | 1977-08-18 | Sandoz Ag | Neue organische verbindungen, ihre herstellung und verwendung |
BE851310A (fr) * | 1976-02-12 | 1977-08-10 | Sandoz Sa | Nouveaux derives de la tetrahydro-equinocandine b |
DE2742435A1 (de) * | 1976-09-28 | 1978-04-06 | Sandoz Ag | Aminoalkylaether der peptide tetrahydro- sl 7810/f-ii, s 31794/f-1, aculeacin a und tetrahydroechinocandin b, ihre verwendung und herstellung |
US4293489A (en) * | 1979-12-13 | 1981-10-06 | Eli Lilly And Company | Derivatives of A-30912A nucleus |
US4293485A (en) * | 1979-12-13 | 1981-10-06 | Eli Lilly And Company | Derivatives of S31794/F-1 nucleus |
US4320053A (en) * | 1979-12-13 | 1982-03-16 | Eli Lilly And Company | Derivatives of A-30912D nucleus |
US4287120A (en) * | 1979-12-13 | 1981-09-01 | Eli Lilly And Company | Derivatives of S31794/F-1 nucleus |
EP0030844A1 (en) * | 1979-12-13 | 1981-06-24 | Eli Lilly And Company | Recovery process for A-30912 antibiotics |
DE3030554A1 (de) * | 1980-08-13 | 1982-03-25 | Chemische Werke Hüls AG, 4370 Marl | Einbrennlacke |
US4931352A (en) * | 1987-10-07 | 1990-06-05 | Merck & Co., Inc. | Antifungal fermentation product |
DK173802B1 (da) * | 1988-09-12 | 2001-11-05 | Merck & Co Inc | Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner |
US5166135A (en) * | 1988-09-12 | 1992-11-24 | Merck & Company, Inc. | Method for the control of pneumocystis carinii |
US5194377A (en) * | 1989-06-30 | 1993-03-16 | Merck & Co., Inc. | Antibiotic agent |
NZ234225A (en) * | 1989-06-30 | 1993-09-27 | Merck & Co Inc | Antibiotic from zalerion arboricola and its use as an antifungal agent and antipneumocystis agent |
US5021341A (en) * | 1990-03-12 | 1991-06-04 | Merck & Co., Inc. | Antibiotic agent produced by the cultivation of Zalerion microorganism in the presence of mannitol |
US5202309A (en) * | 1989-06-30 | 1993-04-13 | Merck & Co., Inc. | Antibiotic cyclopeptide fermentation product |
GB8925593D0 (en) * | 1989-11-13 | 1990-01-04 | Fujisawa Pharmaceutical Co | Fr901379 substance and preparation thereof |
US5159059A (en) * | 1990-05-29 | 1992-10-27 | Merck & Co., Inc. | Process for reduction of certain cyclohexapeptide compounds |
NZ247149A (en) * | 1992-03-19 | 1996-10-28 | Lilly Co Eli | Cyclic peptide antifungal agents and compositions thereof |
US5378804A (en) * | 1993-03-16 | 1995-01-03 | Merck & Co., Inc. | Aza cyclohexapeptide compounds |
US5516757A (en) * | 1994-09-16 | 1996-05-14 | Merck & Co., Inc. | Semi-synthetic lipopeptides, compositions containing said lipopeptides, and methods of use |
US5516756A (en) * | 1994-10-31 | 1996-05-14 | Merck & Co., Inc. | Aza cyclohexapeptide compounds |
-
1993
- 1993-03-16 US US08/032,847 patent/US5378804A/en not_active Expired - Lifetime
-
1994
- 1994-03-08 IL IL10889294A patent/IL108892A/en not_active IP Right Cessation
- 1994-03-09 ES ES94200604T patent/ES2139043T3/es not_active Expired - Lifetime
- 1994-03-09 DK DK94200604T patent/DK0620232T3/da active
- 1994-03-09 DE DE69421639T patent/DE69421639T2/de not_active Expired - Lifetime
- 1994-03-09 DE DE10299013C patent/DE10299013I2/de active Active
- 1994-03-09 EP EP94200604A patent/EP0620232B1/en not_active Expired - Lifetime
- 1994-03-09 AT AT94200604T patent/ATE186736T1/de active
- 1994-03-10 CA CA002118757A patent/CA2118757C/en not_active Expired - Lifetime
- 1994-03-10 RU RU95121639A patent/RU2122548C1/ru active
- 1994-03-10 CZ CZ19952358A patent/CZ286235B6/cs not_active IP Right Cessation
- 1994-03-10 WO PCT/US1994/002580 patent/WO1994021677A1/en active IP Right Grant
- 1994-03-10 PL PL94310634A patent/PL179261B1/pl unknown
- 1994-03-10 NZ NZ263360A patent/NZ263360A/xx not_active IP Right Cessation
- 1994-03-10 HU HU9502703A patent/HU217614B/hu unknown
- 1994-03-10 RO RO95-01594A patent/RO113246B1/ro unknown
- 1994-03-10 KR KR1019950703954A patent/KR100329693B1/ko active IP Right Grant
- 1994-03-10 HR HR940161A patent/HRP940161B1/xx not_active IP Right Cessation
- 1994-03-10 SI SI9420013A patent/SI9420013B/sl unknown
- 1994-03-10 CN CN94191487A patent/CN1098274C/zh not_active Expired - Lifetime
- 1994-03-10 BR BR9406009A patent/BR9406009A/pt not_active Application Discontinuation
- 1994-03-10 SK SK1136-95A patent/SK282527B6/sk not_active IP Right Cessation
- 1994-03-15 JP JP6044091A patent/JP2568474B2/ja not_active Expired - Lifetime
- 1994-03-15 ZA ZA941807A patent/ZA941807B/xx unknown
- 1994-03-15 AU AU57832/94A patent/AU668804B2/en not_active Expired
- 1994-08-29 US US08/298,479 patent/US5514650A/en not_active Expired - Lifetime
- 1994-10-03 UA UA95094151A patent/UA59329C2/ru unknown
-
1995
- 1995-06-29 HU HU95P/P00565P patent/HU211890A9/hu unknown
- 1995-09-13 BG BG99999A patent/BG63047B1/bg unknown
- 1995-09-14 FI FI954327A patent/FI109542B/fi not_active IP Right Cessation
- 1995-09-15 NO NO19953648A patent/NO318372B1/no not_active IP Right Cessation
-
1996
- 1996-10-28 US US08/741,645 patent/US5792746A/en not_active Expired - Lifetime
-
1997
- 1997-04-16 BR BR1100273-5A patent/BR1100273A/pt active IP Right Grant
-
1998
- 1998-07-20 HK HK98109267A patent/HK1008674A1/xx not_active IP Right Cessation
-
1999
- 1999-11-18 GR GR990402878T patent/GR3031872T3/el unknown
-
2000
- 2000-09-07 LV LVP-00-119A patent/LV12574B/en unknown
-
2001
- 2001-12-18 NL NL300076C patent/NL300076I2/nl unknown
-
2002
- 2002-01-03 LU LU90875C patent/LU90875I2/xx unknown
-
2005
- 2005-09-13 NO NO2005020C patent/NO2005020I2/no unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU95121639A (ru) | Аза циклогексапептидные соединения | |
KR960701092A (ko) | 아자 사이클로헥사펩타이드 화합물(Aza cyclohexapeptide compounds) | |
CA2061607A1 (en) | 1-biphenylimidazole derivatives, their preparation and their therapeutic use | |
NZ332363A (en) | substituted 4-hydroxy-isoquinoline-3carboxamide derivatives and medicaments | |
DE68917023D1 (de) | 3-Pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-en-2-carbonsäureverbindungen. | |
EP0632036A3 (en) | Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses | |
ES2133324T3 (es) | Compuestos de dibenzoxazepina sustituidos, composiciones farmaceuticas y metodos de uso. | |
IL106307A (en) | Isoxazole derivatives for the treatment of irritable bowel syndrome | |
ZA89389B (en) | Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia | |
HU9202642D0 (en) | Method for producing piperidine derivatives and pharmaceutical preparatives containing said compounds as active substance | |
ATE103585T1 (de) | Polyamin-derivate als antineoplastische wirkstoffe. | |
KR900001715A (ko) | Bu-3608 유도체 | |
NO923413D0 (no) | Terapeutiske benzazepin-forbindelser | |
HU893127D0 (en) | Process for the preparation of novel spiro-(imidazolidino-naphtaline) derivatives and pharmaceutical compositions containing such compounds as active ingredient | |
GB8829593D0 (en) | Novel compounds | |
GB1057667A (en) | Substituted anthranilamides and process for the preparation thereof | |
IL81337A (en) | Heptanoyl-glu-asp-ala-amino acid immunostimulants,process for their preparation and pharmaceutical compositions containing them | |
KR890003378A (ko) | 혐기성균에 대해 항균작용을 갖는 나프티리딘 화합물 | |
FR2597097B1 (fr) | Derives de benzothiazepine-1, 5, leur preparation et leur application en therapeutique | |
CA2038025A1 (en) | Optically active alkylenedioxybenzene derivatives and their use in therapy | |
KR890003755A (ko) | 7- (2- 메틸- 4- 아미노피롤리디닐)나프티리딘 및 퀴놀린 화합물 | |
KR910006322A (ko) | 펩티딜 디플루오로디올 레닌 억제제 | |
DE3665593D1 (en) | Peptide immunostimulants | |
TW223065B (ru) | ||
KR920011486A (ko) | 항종양제 |